Dr. Reed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
757 Westwood Plz Ste 7501
Los Angeles, CA 90095Phone+1 310-825-8307Fax+1 310-267-3643
Summary
- Dr. Jarred Reed is an internal medicine physician based in Los Angeles, California with a subspecialty in Hematology/Oncology. He completed his residency in Internal Medicine at UCLA David Geffen School of Medicine/UCLA Medical Center from 2013 to 2016. This was followed by a Fellowship in Hematology and Medical Oncology from 2017 to 2020 at Olive View/UCLA Medical Center. He is a graduate of Duke University School of Medicine, Class of 2013. Dr. Reed is also published, with a noteworthy publication on the usage of tyrosine kinase inhibitors in treating renal cell carcinoma.
Education & Training
- Olive View/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2013 - 2016
- Duke University School of MedicineClass of 2013
Certifications & Licensure
- CA State Medical License 2015 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsCombination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?Jacob J. Adashek, Jarred P. Reed, Ankita Tandon, Stephen J. Freedland, Edwin M. Posadas
Clinical Genitourinary Cancer. 2020-05-11 - 15 citationsGut microbiome, antibiotic use, and immunotherapy responsiveness in cancer.Jarred P. Reed, Suzanne Devkota, Robert A. Figlin
Annals of Translational Medicine. 2019-10-22 - 6 citationsBrain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and Heterogeneous.Jarred P. Reed, Edwin M. Posadas, Robert A. Figlin
Journal of Clinical Oncology. 2019-06-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: